Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Other Stockholder Equity

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Other-Stockholder-Equity" stands at 4.29 Trillion Japanese Yens as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Other Stockholder Equity" stands at 4.29 Trillion JPY. This represents an increase of 157.41 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.58 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is 2.58 Trillion Japanese Yens.
The 3 year change is 2.70 Trillion Japanese Yens.
The 5 year change is 2.68 Trillion Japanese Yens.
The 10 year change is 4.26 Trillion Japanese Yens.

The Serie's long term average value is 0.76 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 3.53 Trillion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 09/30/2012, to it's latest available value, on 09/30/2025, is +4.69 Trillion.
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 Trillion.

Other Stockholder Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Stockholder Equity905,699,262,464.00
LogoJohnson & Johnson - Other Stockholder Equity486,508,953,600.00
LogoAbbVie Inc - Other Stockholder Equity399,570,305,024.00
LogoRoche Holding AG - Other Stockholder Equity317,433,206,677.55
LogoAstraZeneca PLC - Other Stockholder Equity280,205,508,085.11